$APRI Headlines Apricus Biosciences up 15% in

$APRI Headlines

Apricus Biosciences up 15% in premarket 6:50 a.m. Oct. 1, 2012 - Steve Gelsi
Thursday’s biggest gaining and declining stocks 2:39 p.m. Sept. 13, 2012 - MarketWatch
Apricus prices stock offering at 13% discount 10:38 a.m. Feb. 9, 2012 - MarketWatch.com
Drug stocks mixed; Regeneron rallies 3:06 p.m. Nov. 22, 2010 - Val Brickates Kennedy
Apricus rockets on liver cancer drug update 10:27 a.m. Nov. 22, 2010 - Val Brickates Kennedy
Updates, advisories and surprises 4:31 p.m. Sept. 29, 2010 - MarketWatch
Apricus Biosciences drops 20% after unit offering 8:29 a.m. Sept. 29, 2010 - Steve Gelsi

BioLineRx Finishes Dose-Escalation in Phase I BL-8040 Study - Analyst Blog 1:40 p.m. Jan. 8, 2015 - Zacks.com
Radius Health (RDUS) Jumps: Stock Adds 5.7% in Session - Tale of the Tape 9:11 a.m. Jan. 8, 2015 - Zacks.com
Zacks Rank #1 Additions for Wednesday - Tale of the Tape 9:30 a.m. Jan. 7, 2015 - Zacks.com
Will Apricus Biosciences (APRI) Continue to Surge Higher? - Tale of the Tape 8:45 a.m. Jan. 7, 2015 - Zacks.com
Onconova Therapeutics (ONTX) Looks Good: Stock Surges 18.2% - Tale of the Tape 9:11 a.m. Jan. 5, 2015 - Zacks.com
MediWound Ltd. (MDWD) in Focus: Stock Jumps 5.6% - Tale of the Tape 9:18 a.m. Jan. 2, 2015 - Zacks.com
OncoGenex to End Deal with Teva & Regain Custirsen Rights - Analyst Blog 2:55 p.m. Dec. 31, 2014 - Zacks.com
Apricus Biosciences And Vitaros: Update On The Launch 1:21 p.m. Dec. 24, 2014 - Seeking Alpha
10-Q: APRICUS BIOSCIENCES, INC. 1:03 p.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Apricus Biosciences' (APRI) CEO Rich Pascoe on Q3 2014 Results -- Earnings Call Transcript 12:29 p.m. Nov. 10, 2014 - Seeking Alpha
Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? 9:50 a.m. Sept. 19, 2014 - Seeking Alpha
Apricus Biosciences: A Screaming Buy Or A Falling Knife? 8:10 a.m. Aug. 25, 2014 - Seeking Alpha
Apricus Biosciences' ED Treatment Vitaros Now in Germany - Analyst Blog 4:10 p.m. Aug. 19, 2014 - Zacks.com
Vitaros launches in Germany 7:20 a.m. Aug. 18, 2014 - Seeking Alpha
Apricus Biosciences' (APRI) CEO Richard Pascoe on Q2 2014 Results - Earnings Call Transcript 10:10 a.m. Aug. 12, 2014 - Seeking Alpha
Apricus Bio closes stock purchase agreement 8:32 a.m. Aug. 12, 2014 - Seeking Alpha
10-Q: APRICUS BIOSCIENCES, INC. 3:11 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Apricus Biosciences Continues To Deliver In Spite Of Bearish Pressures 11:20 a.m. Aug. 5, 2014 - Seeking Alpha
Apricus Biosciences: Stay The Course With This Sexual Health Company 11:44 a.m. July 23, 2014 - Seeking Alpha
Zacks Rank #5 Additions for Wednesday - Tale of the Tape 8:30 a.m. July 16, 2014 - Zacks.com


Building Value: Apricus Biosciences Report Issued by BrokerBank Securities, Inc. 7:00 a.m. Today - PR Newswire - PRF
Apricus Biosciences to Present at Biotech Showcase 2015 7:31 a.m. Jan. 6, 2015 - GlobeNewswire
Apricus Biosciences Announces Year-End 2014 Update and 2015 Plans to Advance Its Clinical Pipeline and Further Commercialize Its Erectile Dysfunction Drug Vitaros(R) 7:30 a.m. Dec. 22, 2014 - GlobeNewswire
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer 7:30 a.m. Dec. 15, 2014 - GlobeNewswire
Apricus Biosciences Announces First Patient Enrolled in Phase 2a Clinical Trial for RayVa(TM) in Patients With Raynaud's Phenomenon 7:31 a.m. Dec. 4, 2014 - GlobeNewswire
Apricus Biosciences Appoints Brian T. Dorsey as Chief Development Officer 7:31 a.m. Dec. 2, 2014 - GlobeNewswire
Apricus Biosciences Announces Third Quarter 2014 Financial Results and Provides Corporate Update 7:01 a.m. Nov. 10, 2014 - GlobeNewswire
Apricus Biosciences to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Monday, November 10, 2014 4:06 p.m. Nov. 7, 2014 - ACCESSWIRE
Apricus Biosciences to Present at Three Upcoming Investor Conferences in November and December of 2014 7:31 a.m. Nov. 5, 2014 - GlobeNewswire
Apricus Biosciences Announces Corporate Update and Third Quarter 2014 Financial Results Conference Call 7:31 a.m. Nov. 4, 2014 - GlobeNewswire
Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Belgium by Sandoz 6:01 a.m. Nov. 3, 2014 - GlobeNewswire
RECORDATI : REVENUE GROWTH AND SIGNIFICAT MARGIN IMPROVEMENT IN FIRST NINE MONTHS 2014 RESULTS. 6:42 a.m. Oct. 28, 2014 - GlobeNewswire
Apricus Expands Development Pipeline With the In-Licensing of U.S. Rights for Fispemifene, a Phase 2b Ready Asset, From Forendo Pharma Targeting Urological Conditions in Men 1:00 a.m. Oct. 20, 2014 - GlobeNewswire
Apricus Biosciences Announces Notice of Allowance of U.S. Patent Application for RayVa(TM) 6:01 a.m. Oct. 13, 2014 - GlobeNewswire
Apricus Biosciences to Present at the 13th Annual BIO Investor Forum 6:31 a.m. Oct. 1, 2014 - GlobeNewswire
Apricus CEO to Discuss Company's Drug Portfolio, Including Its Topical Cream for Erectile Dysfunction, Vitaros(R), LIVE on iHeart (Clear Channel) Business Talk Radio DFW 1190AM on Sept. 25, 2014 1:37 p.m. Sept. 24, 2014 - Marketwire
Apricus Biosciences to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 6:31 a.m. Sept. 3, 2014 - GlobeNewswire
Apricus Biosciences Provides Corporate Update and Second Quarter 2014 Financial Results 6:02 a.m. Aug. 12, 2014 - GlobeNewswire
Apricus Biosciences Enters Into Common Stock Purchase Agreement With Aspire Capital 6:01 a.m. Aug. 12, 2014 - GlobeNewswire
Apricus Biosciences to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Tuesday, August 12, 2014 3:17 p.m. Aug. 11, 2014 - ACCESSWIRE